Histogenics Corporation to Present at 5th Annual Cell & Gene Therapy Investor Day on April 27, 2017 – Nasdaq
|
Histogenics Corporation to Present at 5th Annual Cell & Gene Therapy Investor Day on April 27, 2017
Nasdaq The event includes clinical and commercial experts who are on-hand to address specific questions regarding the outlook for these products, as well as offer insight into how cell and gene therapies could impact the standard of care in key therapeutic … ViaCyte to Present at ARM’s 5th Annual Cell & Gene Therapy …PR Newswire (press release) Homology Medicines Announces Four Presentations on its Gene …Yahoo Finance Sangamo Therapeutics Announces Participation In The ARM 5th Annual Cell & Gene Therapy Investor DayGuruFocus.com EconoTimes –P&T Community –Stockhouse all 8 news articles » |
National Hog Farmer |
‘CRISPR pill’ instructs harmful bacteria to self-destruct
National Hog Farmer One way to do that: a “CRISPR pill” that instructs harmful bacteria to self-destruct. CRISPR is the powerful gene-editing technology already being explored as a way to precisely edit human genes to cure diseases. But the technology’s versatility is … |
|
Sangamo Therapeutics Announces Participation In The ARM 5th Annual Cell & Gene Therapy Investor Day
PR Newswire (press release) Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic therapies that transform patients’ lives using the company’s industry leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. |
EurekAlert (press release) |
Implanted scaffold with T cells rapidly shrinks tumors Fred Hutchinson Cancer Research Center
EurekAlert (press release) IMAGE: This is a diagram of a scaffold loaded with CAR T cells and “microspheres ” containing nutrients to help the cells multiply and then leave the scaffold to go attack cancer… view more. Credit: Image by Cognition Studio, courtesy of Fred … |